Effectiveness of a Cardiac Rehabilitation Program in Elderly Patients With Heart Failure.
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Heart Failure With Preserved Ejection Fraction
Related studies linked through entity extraction aliases.
Exercise Capacity Before and After AF Ablation in Patients With HFpEF
- Status
- UNKNOWN
- Phase
- N/A
NMES in HF Patients to Improve Functional Recovery Following Hospitalization
- Status
- COMPLETED
- Phase
- NA
Single-Ascending Dose Study of JK07 in Subjects With HFpEF
- Status
- WITHDRAWN
- Phase
- PHASE1
Selective PDE9 Inhibition With IMR-687 in Adults With Heart Failure With Preserved Ejection Fraction
- Status
- WITHDRAWN
- Phase
- PHASE2
Exploratory Ph 2A, Double-Blind, Placebo-Controlled Dose Escalation Study of Safety, Tolerability, PD, & PK of HU6 for Subjects With Obese HFpEF
- Status
- COMPLETED
- Phase
- PHASE2
Enhancing the Natriuretic Peptide System in HFpEF
- Status
- ENROLLING_BY_INVITATION
- Phase
- PHASE1/PHASE2
The Effect of a High Fiber Diet and High-Intensity Interval Exercise in Patients With HFpEF
- Status
- RECRUITING
- Phase
- NA
Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Cardiovascular Effects.
- Status
- COMPLETED
- Phase
- NA
PErirenal Adipose Tissue and RenaL Hemodynamics in Patients With Heart Failure With Preserved Ejection Fraction
- Status
- UNKNOWN
- Phase
- N/A
Follow Up of acuTe Heart failUre: a pRospective Echocardiographic and Clinical Study (FUTURE)
- Status
- UNKNOWN
- Phase
- N/A
Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction
- Status
- RECRUITING
- Phase
- NA
Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Metabolic Effects. (KETO-HFpEF-Metabolic)
- Status
- COMPLETED
- Phase
- NA
Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction
- Status
- COMPLETED
- Phase
- PHASE4
SGLT2i and KNO3 in HFpEF - The SAK HFpEF Trial
- Status
- RECRUITING
- Phase
- PHASE2
Polydiuretic Therapy for HFpEF, a Randomised Controlled Trial
- Status
- TERMINATED
- Phase
- PHASE4
Cilostazol for HFpEF
- Status
- COMPLETED
- Phase
- PHASE2
"HerzCheck" - Detection of Early Heart Failure Using Telemedicine in Structurally Weak Regions
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
Heart Failure With Preserved Ejection Fraction: Evaluation and Recognition by CMR
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Relationship Between Adipose Tissue Distribution and Arterial Stiffness in HFpEF
- Status
- UNKNOWN
- Phase
- N/A